| Price | 484.00p on 02-04-2026 at 15:57:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 500.00p |
| Sell | 468.00p |
| Last Trade: | Buy 603.00 at 496.80p |
| Day's Volume: | 608 |
| Last Close: | 484.00p |
| Open: | 484.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 484.00p - 484.00p |
| 52wk Range: | 474.00p - 1,200.00p |
| Market Capitalisation: | £74.95m |
| VWAP: | 496.60263p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 603 | 496.80p | Ordinary |
13:14:40 - 02-Apr-26 |
| Buy* | 39 | 496.80p | Ordinary |
10:54:31 - 01-Apr-26 |
| Buy* | 200 | 496.80p | Ordinary |
08:25:12 - 01-Apr-26 |
| Sell* | 3 | 468.00p | Ordinary |
08:02:55 - 01-Apr-26 |
| Buy* | 200 | 479.00p | Ordinary |
15:14:10 - 31-Mar-26 |
| Unknown* | 2,086 | 479.00p | Ordinary |
11:12:59 - 31-Mar-26 |
| Sell* | 25 | 471.266p | Ordinary |
11:10:25 - 31-Mar-26 |
| Buy* | 10 | 488.00p | Ordinary |
08:30:08 - 31-Mar-26 |
| Buy* | 160 | 488.00p | Ordinary |
13:12:24 - 30-Mar-26 |
| Buy* | 190 | 488.00p | Ordinary |
13:12:20 - 30-Mar-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Mar 2026 7:00 am | PRN | Lease of Manufacturing Facility |
| 12th Mar 2026 7:00 am | PRN | Appointment of COO |
| 3rd Mar 2026 7:00 am | PRN | Appointment of CCO |
| 16th Feb 2026 7:00 am | PRN | Director Dealing |
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
| 10th Feb 2026 7:00 am | PRN | Leadership Changes |
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
